SUMMARY The effects of antimalarials, chloroquine and quinacrine, on the generation of reactive oxygen species were examined both in polymorphonuclear leucocytes and in the xanthine-xanthine oxidase system. Antimalarials showed inhibitory effects on the production of reactive oxygen species probably by affecting cell functions, such as membrane phospholipid methylation. It is suggested that antimalarial agents can work as antioxidants at the site of inflammation protecting against auto-oxidative tissue damage with resultant anti-inflammatory effects. method.'5 After centrifugation of the blood over a Ficoll-Hypaque gradient the cell pellet containing PMNs and erythrocytes was washed with saline solution and resuspended in plasma containing dextran 170 (mol. wt 170 000) at a final concentration of 1%. PMNs were recovered after sedimentation at unit gravity, and the few contaminating erythrocytes were lysed by treatment of the preparation with 0-876% NH4Cl. The PMNs were then resuspended in Krebs-Ringer phosphate buffer (KRP), containing 5 mM glucose and 1 mg/ml (g/l) gelatin, for assays of ROS. Gelatin was added in order to prevent PMNs from adhering to the test tubes but was excluded from the medium for OH generation assay on account of its inhibitory effect.
Although antimalarial drugs have a number of effects both in vitro and in vivo,3 4 the precise reasons for their efficacy have not been determined.
We have recently shown that reactive oxygen species (ROS) are involved in the pathogenesis of several inflammatory disordersS' l and that the mechanism of action of some anti-inflammatory agents is partly ascribable to their antioxidant effects on the inflammatory process.'2-14
In the present study we asked if antimalarials have inhibitory effects on ROS generation by polymorphonuclear leucocytes (PMNs) and in the xanthinexanthine oxidase system.
Materials and methods

CHEMICALS
Chloroquine and quinacrine were purchased from Sigma Chemical Co., St Louis, MO, USA.
PREPARATION OF PMNs FOR ROS ASSAYS
PMNs were prepared from the heparinised peripheral venous blood by a previously described Accepted for publication 5 1 mg/ml opsonised zymosan for 10 min at room temperature 0*1 ml of 50 mM scopoletin in KRP and 0-1 ml of 1 mg/ml horseradish peroxidase (type II, Sigma) in phosphate-buffered saline (PBS) were added. The rate of decrease in fluorescence intensity of the scopoletin within 30 min was quantified in a fluorescence spectrophotometer (Hitachi). Incubation of supernatants with an excess of 600 U/ml catalase inhibited fluorescence reduction. Catalase heated at 130°C for 30 min served as a control. OH was quantified by the amount of ethylene gas formed from a-ketomethiolbutyric acid (KMB, SiTma) plus OH generated by PMNs.'8 PMNs (2x 10) in 2 ml KRP were preincubated with 1 mM KMB at 37°C for 5 min. After 1 mg/ml opsonised zymosan was added incubation was continued for a further 10 min. The amounts of OH gas formation were assayed at 30 min on a gas chromatograph (Hitachi). The simultaneous addition of 10 mM benzoate into the PMN medium reduced peak OH generation by 75%. Chemiluminescence was measured in a scintillation spectrometer (Packard, IL, USA), according to Allen and Loose'9 with slight modification. PMNs (5x 106) in 3 ml colourless Hanks's solution containing gelatin were incubated at 37°C for 10 min with opsonised zymosan in the absence of luminol. Chemiluminescence was monitored on the spectrometer, which was operated in out-of-coincidence summation mode. All procedures were performed in the dark. Incubation of the PMNs plus opsonised zymosan with 2 mM xanthine reduced peak chemiluminescence by 70%.
EFFECTS OF ANTIMALARIALS ON THE GENERATION OF ROS FROM PMNs
Both chloroquine and quinacrine were dissolved in the solution of PBS, and this solution was added to the PMN-suspended medium of each ROS assay system to final concentrations of 1, 10, 100, and 1000 lAg/ml (mg/l). The same volume of PBS was added to the control.
EFFECTS OF ANTIMALARIALS ON ROS GENERATION IN XANTHINE-XANTHINE OXIDASE SYSTEM
In separate experiments the effects of antimalarials on ROS generation were also examined in the xanthine-xanthine oxidase system. Instead of adding PMNs and opsonised zymosan, 0-1 ml of 13-5 mg hypoxanthine in 50 ml physiological saline plus 0-05 ml of 50 mM ethylenediaminetetra-acetic acid were diluted in 2 ml of KRP (pH 7.2-7-4). Then antimalarials in PBS were added to the medium to final concentrations of 1, 10, 100, and 1000 [tg/ml.
The same volume of PBS was added to the control. Thereafter 0-1 ml of 0-1 unit/ml dialysed xanthine oxidase was added to generate ROS, and each ROS was determined respectively as described above.
Results
EFFECTS OF ANTIMALARIALS ON
SUPEROXIDE (O°2) GENERATION (Fig. 1) As shown in Fig. 1 GENERATION (Fig. 2) Addition of quinacrine resulted in a significant --decrease in H202 generation by PMNs dose depen-E \ dently, and almost negligible H202 was detected at Q drug concentrations higher than 100 sg/ml. This \Txanthine-xanthine oxidase system no significant &0 5 inhibition was observed at lower concentrations either T by chloroquine (_----) or quinacrine (@-). (Fig. 4) oxidase system (_n---U In the present investigation we have shown the antioxidant action of antimalarials in a zymosan stimulated PMN system. Quinacrine reduced the generation of all ROS examined in a dose dependent way. Chloroquine also had inhibitory effects on O2 and OH production, and on chemiluminescence. In contrast these antimalarial drugs showed no suppressive effect on ROS generation in the xanthine-xanthine oxidase system at the concentrations expected after the administration of therapeutic doses, while they decreased ROS levels at higher concentrations. In view of these facts it is suggested that antimalarials inhibit ROS generation by affecting PMN functions at therapeutic doses and exert a ROS scavenging effect at higher concentrations. Although the plasma levels of antimalarials remain low, in the range of 90-170 ,u/l, after the administration of therapeutic doses, the tissue concentrations are considered to be extremely high.26 27 Thus it is possible that these agents can work as antioxidants at the site of inflammation, though the potential of the metabolic products of antimalarials to influence the ROS systems are unknown.
Of great interest is the recent finding that quinacrine is a phospholipase A2 inhibitor, 8 
